Literature DB >> 2581711

Reduction in RNA synthesis following red cell-mediated microinjection of antibodies to RNA polymerase I.

R A Schlegel, L S Miller, K M Rose.   

Abstract

Antibody molecules directed against RNA polymerase I, the enzyme responsible for rRNA synthesis, were introduced into rat hepatoma cells by red cell-mediated microinjection. Access of the antibodies to the nucleolus, the site of rRNA synthesis, was facilitated by microinjecting mitotic cells. Using indirect immunofluorescence, anti-RNA polymerase I immunoglobulins, but not control immunoglobulins, were found localized in the nucleoli of microinjected cells. To assess whether intracellular antibodies could alter RNA synthesis, cultures were labeled with [3H] uridine at various times after microinjection. Reduction in RNA synthesis, relative to cells microinjected with non-immune immunoglobulins, was observed within three hours. These results demonstrate that antibodies introduced into the cytoplasm of mitotic cells via red cell-mediated microinjection have free access to nuclear components and that they remain functional within the nuclei of living cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581711     DOI: 10.1016/0309-1651(85)90029-3

Source DB:  PubMed          Journal:  Cell Biol Int Rep        ISSN: 0309-1651


  3 in total

Review 1.  Nuclear compartmentalization as a mechanism of quantitative control of gene expression.

Authors:  Prashant Bhat; Drew Honson; Mitchell Guttman
Journal:  Nat Rev Mol Cell Biol       Date:  2021-08-02       Impact factor: 94.444

2.  Nucleolar changes after microinjection of antibodies to RNA polymerase I into the nucleus of mammalian cells.

Authors:  R Benavente; G Reimer; K M Rose; B Hügle-Dörr; U Scheer
Journal:  Chromosoma       Date:  1988       Impact factor: 4.316

3.  Inhibition of nucleolar reformation after microinjection of antibodies to RNA polymerase I into mitotic cells.

Authors:  R Benavente; K M Rose; G Reimer; B Hügle-Dörr; U Scheer
Journal:  J Cell Biol       Date:  1987-10       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.